All Type of News
HIRA announces interim reports of economic effectiveness of drugs in 5 therapeutic categories
The Health Insurance Review and Assessment Service (HIRA) announced on May 28 the interim results of medicines in five therapeutic categories.
Government-screened drugs belonging to the five therapeutic categories ...
Large drugmakers to be hit by double punishment
Korea’s large drug makers are struggling to cope with sluggish sales of their flagship products as external environments are harsh and gloomy.
These days, pharmaceutical companies face the government’s intensive ca...
Leading pharmaceutical firms beleaguered by two-way sanction
Local leading companies are faced with a burden of weakening growth potential, falling profitability and worsening financial soundness in the wake of doctors’ antipathy to them triggered by the crackdown on rebates.
...
Debate over drug utilization review system heats up
A dispute has arisen over the planned introduction next month of a government-imposed review of prescribed drugs.
Doctors have threatened to boycott the Drug Utilization Review (DUR) system, saying it interferes wi...
GSK's pediatric vaccines Synflorix wins international award at 2010 World Vaccine Congress
Synflorix, GlaxoSmithKline’s childhood pneumococcal vaccine, has received outstanding recognition by winning the Best Prophylactic Vaccine at the recent Vaccine Industry Excellence awards held at the 2010 World Vaccin...
Doctors, pharmacists clash over DUR
Disputes are arising between doctors and pharmacists over who gets the right to prescribe medicines to patients in the Drug Utilization Review (DUR) system.
While the pharmacists claim that the doctors should presc...
Hanmi Pharm to split into holding, operating companies
Hanmi Pharm Co., a Korean drugmaker, said on May 28 that it will split into holding and operating entities to simplify its corporate structure and boost investor interest,.
Hanmi Pharm will be separated into two f...
Bukwang receives first royalty over Levovir
Bukwang said it has received a first royalty of US$31,000 from Eisai Co., for the marketing of Levovir capsule (clevudine) in the Philippines.
Levovir has been prescribed in such country after successful registrat...
Most contenders running for June 2 elections disapprove for-profit hospital
Parties had been cautious about drawing the spotlight over major contentious issues, such as the four-river project and corruption scandal allegedly involving prosecutors, amid fears of a backlash in the wake of the s...
Korea United launched novel formulation of aceclofenac tablets
Korea United has launched its novel formulation of aceclofenac tablets, a move that facilitates competition in the domestic analgesic and anti-inflammatory markets.
The drug, called Clanza CR tablet, is characteriz...
